C-LANT Drainage Port (190118979)
https://cordis.europa.eu/project/id/190118979
Horizon Europe (2021-2027)
Life Saving Technology for Thoracic Trauma Treatment and Post Operative Drainage
EIC Accelerator Open (HORIZON-EIC-2022-ACCELERATOROPEN-01)
mortality · emergency medicine
2023-03-01 Start Date (YY-MM-DD)
2025-08-31 End Date (YY-MM-DD)
€ 3,571,250
Description
Thoracic trauma is the 1st cause of accidental death globally, with a mortality rate of 60% in polytraumatic patients. The time of treatment is crucial. 80% of patients can be potentially saved if they are treated in 1h. However, current solutions to treat it are limited and static for the last 30-50 years. C-LANT is a unique self-fixating, a-traumatic and multifunctional device tackling this unmet need by offering a safe, fast, easy to use, multifunctional and cost-effective tool for treating any type of chest trauma or postoperative drainage following major thoracic and abdominal procedures. It reduces the procedure time by 20x and saves up to €2.6Bn associated with additional tube replacement (EU). With the EIC support Vigor aims to accelerate the clinical validation and scaling-up of C-LANT, providing a global impact to healthcare systems, clinicians, and patients. C-LANT will be part of the growing Emergency Medical Devices and the Surgical Drains markets (total valued >40B -2030)
Complicit Organisations
1 Israeli organisation participates in C-LANT Drainage Port.Country | Organisation (ID) | VAT Number | Role | Activity Type | Total Cost | EC Contribution | Net EC Contribution |
---|---|---|---|---|---|---|---|
Israel | VIGOR MEDICAL TECHNOLOGIES LTD (907632202) | IL515105112 | coordinator | PRC | € 3,571,250 | € 2,499,875 | € 2,499,875 |